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Background/aim: The aim of this study was to assess the relationships between the course of Behçet’s disease (BD), disease-specific
fears, and work productivity and activity impairment.
Materials and methods: In this cross-sectional study, 110 consecutive BD patients were included. The Work Productivity and Activity
Impairment questionnaire was used.
Results: In the group of employed patients, 30.41% had missed work during the previous week. The mean percentages of daily activity
impairment were higher in patients with musculoskeletal involvement (39.81 ± 33.61%) compared to those without (23.48 ± 32.45%)
(P = 0.008). A greater decrease in working hours was observed in patients with eye involvement (45.52 ± 15.29 h) compared to those
without (54.15 ± 15.29 h) (P = 0.007). More of the male patients (67.8%) were afraid of losing their jobs compared to females (30%) (P
= 0.000).
Conclusion: The highest levels of lost productivity and the most severe effects on daily life are consequences of eye and musculoskeletal
involvement in the study population. More effective therapeutic approaches are required to improve the working lives of patients with
BD. Moreover, male patients had a higher fear of losing their jobs, suggesting a match between the expected clinical course and the
predictions of BD patients.
Key words: Behçet’s disease, work productivity, activity impairment

1. Introduction
Patient-reported outcome measures are commonly used
in the decision-making process for chronic conditions.
However, disease-related problems often vary among
patients. Uncontrolled symptoms or flare ups of chronic
conditions can cause emotional distress such as fear and
anxiety (1,2). In such circumstances, self-regulation and
coping strategies are utilized by patients to overcome
the psychological impact of the disease (3). However,
limitations arise in cases where the patients are unable to
apply these strategies, especially in the context of fear of
inability to work. Work limitation can be defined as an
outcome measure that evaluates any decrease in the ability
to meet the demands of the job or to maintain employment
under chronic conditions (4,5).
Symptom burden, sex, working hours, and age could be
considered as predictive factors for long-term limitations
* Correspondence: goncamumcu@marmara.edu.tr

(4,6–9). Therefore, work limitation becomes an important
issue for patients as well as health professionals, policymakers, and insurers (4,10). It is well established that lost
productivity can be observed in cases of chronic diseases
such as deep vein thrombosis (11), psoriatic arthritis
(12), spondylarthropathies (10,13,14), systemic lupus
erythematosus (15), autoimmune bullous dermatoses (16),
cardiovascular events (17), psoriasis (18), diabetes mellitus
(19), respiratory disorders and cardiovascular diseases (6),
rheumatoid arthritis (6–9,20), and Behçet’s disease (BD)
(21).
BD, as a chronic multisystemic inflammatory
disorder, is characterized by oral and genital ulcers
and the involvement of the cutaneous (erythema
nodosum, pustular vasculitis), ocular (anterior or
posterior uveitis), musculoskeletal, vascular (both
arterial and venous vasculitis), gastrointestinal, and
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central nervous (meningoencephalitis) systems. In
many cases, the emotional condition and productivity
of patients are affected by the severity of the disease and
the frequency/duration of relapses, which unfortunately
are unpredictable in clinical practice. In addition, both
treatment protocols and prognoses are affected by the
heterogeneity of disease symptoms. In BD, recurrent
painful oral and genital ulcerations and joint pain are the
major restrictive factors for daily life, whereas severe organ
involvements, in particular vascular, neurologic, and
ocular involvement in young male patients, are the major
risk factors for mortality and morbidity. The consequences
of major organ involvement can largely be eliminated
by immunosuppressive medications in BD, whereas
mucocutaneous symptoms, as a mild disease spectrum,
can remain active under a mild antiinflammatory agent
(frequently colchicine)-based protocol (22–25). In
this context, producing new disease-specific or organspecific outcome measures for use in the decision-making
process can be helpful in patient management (22–29).
Productivity loss at work and/or in daily life and diseasespecific fears can be considered as outcome measures in
cases of BD; however, there have been no data presented to
date regarding this issue. Therefore, the aim of this study
was to assess the relationships between the course of BD
and disease-specific fears, work productivity, and activity
impairment.
2. Materials and methods
In this cross-sectional study, 110 consecutive BD patients
(F/M: 50/60, mean age: 38.5 ± 9.88 years) diagnosed
according to International Study Group criteria (30) and
followed at the multidisciplinary Behçet’s Disease Clinics
of the Marmara University School of Medicine in İstanbul
were included. The inclusion criterion was being >18 years
of age, whereas patients with any other chronic physical
and/or mental disorders were excluded. Disease duration
was 8.93 ± 6.84 years. The clinical manifestations of BD
patients were as follows: oral ulcers (100%), genital ulcers
(89.1%), and cutaneous (91.8%), arthritic (49.1%), ocular
(33.6%), vascular (32.7%), neurological (2.7%), and
gastrointestinal involvement (1.8%). A positive pathergy
reaction was observed in 65.5% (n = 72). Six newly
diagnosed patients (5.5%) had not received any treatment.
Forty-eight patients (43.6%) were treated with colchicine
(1–2 mg/day) whereas the others (n = 56, 50.9%) were
treated with immunosuppressive agents.
The patients’ total clinical severity score was determined
as previously described (31). The mean severity score
in the whole group was 4.69 ± 1.54. The patients were
categorized as follows: severe group, ≥4 points (n = 78,
70.9%), and mild group, <4 points (n = 32, 29.1%).
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The study was approved by the Ethics Committee of
the Marmara University Medical School and informed
prior consent was given by all of the involved patients.
2.1. Work productivity and activity impairment
The Work Productivity and Activity Impairment
(WPAI) questionnaire is a 6-item instrument to measure
impairment in both paid and unpaid work (20). The
Turkish version of the form was produced by backward
and forward translations. Scoring procedures are based on
responses regarding the 7 days prior to the administering
of the questionnaire. Patients were asked about their
employment status (question 1, Q1), hours missed from
work due to health problems (Q2) and other reasons (Q3),
hours actually worked (Q4), work productivity (Q5) (0 =
no effect to 10 = severe effect on a 10-mm visual analog
scale).
According to the questionnaire, if the patients were
not currently employed at the time of the study, they were
only required to respond to the last question (Q6), which
was an evaluation of their ability to carry out their daily
activities (0 = no effect to 10 = severe effect). The Turkish
form of the questionnaire was approved by the authors
(RHD, SATE, GNİ, GM) and was applied to 10 patients
in a pilot study. Test-retest reliability was examined in
2–6 days across a clinically stable set of patients (n = 7)
by applying Pearson’s correlation tests. Four subgroup
scores regarding percentages of absenteeism, presenteeism
(reduced productivity at work), overall work impairment
combining presenteeism and absenteeism, and daily
activity impairment outside of the work were calculated.
Percent work time missed due to health: Q2 / Q2 + Q4;
percent impairment due to health: Q5 / 10; percent overall
impairment due to health: Q2 / (Q2 + Q4) + ((1 – Q2 /
(Q2 + Q4) × (Q5 / Q10)); daily activity impairment due
to health: Q6 / 10. These scores were multiplied by 100.
Greater impairment is indicated by high scores in the
subgroups (20).
Cronbach’s alpha value was 0.739 for the last two items
and these had the same scoring method.
2.2. The evaluation of work-related fear
The patients’ emotional presentation, together with their
symptoms and the severity of their disease, was assessed by
open-ended questions. Following this, 7 items that focused
on disease-related fears were formulated by experts (RHD,
SATE, GNİ, GM) and were given to a small group (n = 10).
These items were scored according to a 5-point Likert scale
(1 = strongly agree to 5 = strongly disagree). After some
revisions, the checklist was finalized and administrated.
The answers were categorized into 3 groups (strongly
agree/agree; neutral; disagree/strongly disagree) for the
analysis.
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2.3. Convergent validity
The numbers of days that patients could not do housework
as well as a global rating of their general health (0 = very
poor to 10 = very well) and pain status (0 = severe pain
to 10 = no pain) were evaluated for the previous month.
The correlations among these variables, work-related fear
items, and four subscales of work productivity and activity
impairment were then examined. Four undergraduate
students (FL, ÖF, HÖ, UA), who were not involved in
clinical practice explained the objectives of the study and
helped patients to fill out the questionnaire.
2.4. Statistical analysis
The data were analyzed using SPSS 20.0 (IBM Corp.,
Armonk, NY, USA) in addition to an unpaired t-test,
Pearson’s correlation test, and chi-square tests. The
Mann–Whitney U test and a Spearman correlation
test as nonparametric tests were also carried out on
any nonnormal distributions. Internal consistency was
examined by computing Cronbach’s alpha values.
3. Results
In this study, 110 patients with BD were included. The
mean age was lower in males (34.42 ± 7.76 years) than
females (43.04 ± 10.08 years) (P = 0.000). Across the
group, the mean number of examinations was 4.11 ± 3.06
and the length of stay in the hospital was 1.88 ± 0.32 days
(n = 9) during the previous year.
Sixty percent of the patients (n = 66) were employed
as blue-collar workers. The mean age and disease duration
were found to be lower in the working group (34.45 ±
7.86 and 7.32 ± 5.53 years), whereas their frequency of
examinations (4.24 ± 2.99) during the previous year was
higher than that of the unemployed patients (41.36 ± 12.05
years, 11.1 ± 8.06 years, and 2.96 ± 1.58) (P = 0.035, P =
0.015, P = 0.016, respectively). No significant difference
was observed in the disease severity scores of the working
(4.8 ± 1.62) and nonworking groups (4.41 ± 1.32) (P =
0.20).

Missing hours from work due to illness and overall
working hours were reported as 5.23 ± 15.17 h (n = 12) and
50.16 ± 19.58 h (n = 66) during the previous 7 days (Table
1). Missing work for any other reason was not observed in
the study group.
The working hours were higher in males (52.84 ± 8.64
h) than females (38.54 ± 20.7 h) (P = 0.045). According
to organ involvement, a greater decrease in working hours
was observed in patients with eye involvement (45.52 ±
15.29 h) compared to those without (54.15 ± 15.29 h) (P
= 0.007).
In the working group, 30.41% had missed work during
the previous week. Health interference at work was found
to be mild. The mean values of the four domains were
between 27.27% (regular daily activities outside of work)
and 57.75% (impairment at work due to health) (Table
1). The mean percentages of daily activity impairment
were higher in patients with musculoskeletal involvement
(39.81 ± 33.61%) compared to those without (23.48 ±
32.45%) (P = 0.008). Excellent correlations were found
in domains between the first and second administration
of the questionnaire (correlation coefficients from 0.70 to
0.88, P < 0.05).
As shown in Table 2, over half of the male patients
(67.8%) were more anxious about losing their jobs
compared to females (30%) (P = 0.000). In the WPAI
questionnaire, the scores for impairment at work and
daily activity were higher in patients who were afraid of
being unable to work, being dependent on someone, being
disabled, being unable to carry out daily activities, and
having a stroke (P < 0.05). Increases in the impairment at
work score were observed in patients who had more jobloss fear (P = 0.002). Moreover, patients who were afraid of
being blind had higher levels of daily activity impairment
(P = 0.001) (Table 3).
Scores of the four subgroups in the WPAI questionnaire
weakly correlated with missed days (1.9 ± 4.1) where the
patients were unable to do housework during the previous

Table 1. The evaluation of work productivity and impairment in Behçet’s disease.
Mean ± SD
Patients working for pay (n = 66)
Working hours during the past 7 days

50.16 ± 19.58

Worked time missed, % (12 patients with missed ≥1)

30.41 ± 16.58

Impairment at work, % (38 patients with impairment ≥1)

57.75 ± 24.88

Overall work impairment, % (9 patients with overall impairment ≥1)

45.56 ± 25.29

All patients (n = 110)
Daily activity impairment, % (63 patients with activity impairment ≥1)

27.27 ± 32.70
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Table 2. The distribution of disease-related fears according to sex, disease course, and age in Behçet’s disease.
Sex
I am afraid of….

Agree
1. Being unable
to walk

2. Being
dependent on
someone

3. Being disabled

4. Having a stroke

5. Being blind

6. Being unable to
do daily activities

7. Losing the job

Disease course

Male, n (%)
(n = 60)

Female, n
(%) (n = 50)

35 (58.3)

29 (58)

P*

Age

Mild, n (%)

Severe, n (%)

16 (51.6)

48 (63.2)

15 (48.4)

28 (36.8)

19 (61.3)

50 (65.8)

0.75

P

Mean

SD

38.03

9.5

38.48

10.27

38.09

9.45

Neutral

1 (1.7)

2 (4)

Disagree

24 (40)

19 (38)

Agree

34 (56.7)

35 (70)

Neutral

2 (3.3)

1 (2)

Disagree

24 (40)

14 (28)

12 (38.7)

26 (34.2)

39.06

10.91

Agree

35 (58.3)

34 (68)

17 (56.7)

52 (70.,3)

37.87

9.31

Neutral

2 (3.3)

4 (8)

Disagree

23 (38.3)

12 (24)

13 (43.3)

22 (29.7)

38.66

11.22

Agree

38 (60)

32 (64)

16 (53.3)

52 (70.3)

38.82

9.44

14 (46.7)

22 (29.7)

38.72

10.83

22 (71)

64 (84.2)

39.06

9.93

P

0.28

0.35

0.83

0.66

0.19

0.65

0.25

0.41

0.72

Neutral

2 (3.3)

4 (8)

Disagree

22 (36.7)

14 (28)

0.11

Agree

44 (73.3)

42 (84)

Neutral

2 (3.3)

1 (2)

Disagree

14 (23.3)

7 (14)

9 (29)

12 (15.8)

35.61

9.46

Agree

42 (70)

34 (74)

20 (66.7)

59 (76.6)

37.91

9.71

40

10.51

36.8

9.18

40.6

10.25

0.40

0.68

0.17

Neutral

1 (1.7)

2 (4)

Disagree

17 (28.3)

11 (229)

0.59
10 (33.3)

18 (23.4)

Agree

40 (67.8)

15 (30)

14 (45.2)

41 (53.9)

Neutral

1 (1.7)

1 (2)

Disagree

18 (30.5)

34 (68)

17 (54.8)

35 (46.1)

0.18

0.33

0.39

0.52

0.000

0.06

* Chi-square test, agree vs. disagree.
Table 3. The relationships among disease-related fear, productivity, and daily activity in working patients with Behçet’s disease.
Impairment at work, %

I am afraid of…
Being unable to walk
Being dependent on someone
Being disabled
Being unable to do daily activities
Having a stroke
Being blind
Losing the job
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Mean

SD

Strongly agree/agree

41.07

34.84

Strongly disagree/disagree

18.54

28.03

Strongly agree/agree

39.64

33.86

Strongly disagree/disagree

21.52

32.45

Strongly agree/agree

40.35

33.32

Strongly disagree/disagree

22.14

33.63

Strongly agree/agree

38.43

34.05

Strongly disagree/disagree

15.01

28.28

Strongly agree/agree

40.60

33.69

Strongly disagree/disagree

22.5

33.86

Strongly agree/agree

-

-

Strongly disagree/disagree

-

-

Strongly agree/agree

42.19

34.18

Strongly disagree/disagree

17.6

28.47

Daily activity impairment, %
P
0.004
0.021
0.022
0.006
0.024
0.002

Mean

SD

40.85

34.35

18.13

28.47

40.65

34.01

17.1

28.65

40.21

33.43

19.42

31.33

39.18

34.25

10.35

22.52

40.8

33.31

18.88

31.05

35.52

33.13

19.04

35.2

-

-

-

-

P
0.000
0.000
0.002
0.000
0.011
0.001
-

MUMCU et al. / Turk J Med Sci
month. Global patient health and pain scores negatively
correlated with impairment at work and daily activities.
As predicted, age had a weakly negative correlation with
impairment at work (Table 4).
The patient global pain score weakly correlated
with some items regarding being unable to work, being
dependent on someone, being disabled, having a stroke,
and being unable to carry out daily activities (P < 0.05).
However, it also weakly correlated with global patient
general health and the number of days that patients were
unable to do housework (P < 0.05).

could be predicted since recurrent eye involvement
regarding recurrent uveitis, retinal vasculitis, and sequelae
can all be linked to limitations in the ability to work.
In BD, direct medication costs are observed to be
higher mainly in cases of neurological involvement (33).
However, indirect costs could be hidden or not quantified
easily. Healthcare resource use as direct cost alone cannot
reflect the burden of a disease since work-related outcomes
such as sick leave, disability, poor work performance,
activity limitations, restricted daily activities and bed days
(34,35), premature retirement (36), and loss of income
are key parameters for the assessment of chronic disease
management (11,35,37). Therefore, impairment of work
productivity and daily activities should be evaluated and
minimized due to their socioeconomic consequences
(11,37).
In the present study, WPAI scores were interrelated
with poor general health, levels of pain, and days of
missed housework. BD patients with musculoskeletal
involvement were found to be affected according to the
WPAI questionnaire. The impairment of their productivity
at work and in their regular daily activities was related to
their levels of pain. In the working group, age was lower
and utilization of health services was higher. This could
be related both to having an active disease course and its
effects on working life. Musculoskeletal diseases can affect
both work ability and productivity at work (5,38). Lower
functional status (8), level of pain (5,9,36), and patient
age (8) could be predictive factors for work disability in
cases of rheumatoid arthritis. However, nonerosive and
nondeforming oligoarthritis in cases of BD might be
expected to cause less severe disease course compared
to RA. Nevertheless, there is an unmet need for better
treatment options enabling more effective disease control
leading to resolution of symptoms.
The lack of a significant relationship between
vascular involvement and work productivity and activity
impairment was surprising and an unexpected finding of
the study. This may be explained by the control of vascular

4. Discussion
Disease-specific fears can be related to clinical course
as well as social burden and the economic impact of
the disease itself, and these are clearly expressed by
symptomatic patients (2). In the present study, diseasespecific fear was assessed according to sex, age, and disease
course. Males were more anxious about losing their jobs.
Most of the male patients were manual workers with
long working hours. They might have more emotional
distress due to the economic impact of disease symptoms
because men are the main workforce in Turkish culture.
Moreover, as severe organ involvement is a risk factor
for mortality and morbidity in young male patients,
aggressive treatment protocols with immunosuppressive
medications are commonly used to eliminate these risks
(22–24). Therefore, our results reflect the predictions and
perceptions of patients on the clinical course of BD.
In the present study, the mean self-reported weekly
working hours were found to be longer in males compared
to females, which is in line with predictions. However,
their self-reported 52 h of weekly working time was well
above legal regulations in Turkey (45 h/week) (32). The
reason for working long hours may also be related to the
fear of losing jobs in male patients.
When the data were analyzed according to organ
involvement, a greater decrease in working hours was
observed in patients with ocular involvement. This result

Table 4. Work productivity and impairment-related factors in patients with Behçet’s disease.
Impairment
at work, %

Daily activity
Impairment, %

Work time,
%

r

P

r

P

r

P

r

P

The number of days that patients
were unable to do housework

0.28

0.032

0.54

0.000

0.35

0.005

0.36

0.04

General health

–0.26

0.029

–0.26

0.006

Pain

–0.47

0.000

–0.42

0.000

Age

–0.27

0.037

During the last month ……..

Overall impairment,
%
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inflammation and flare ups with more aggressive and
effective management strategies in our patients. Moreover,
the evaluation period for work limitations was very short in
this cross-sectional study. Therefore, repeated assessments
in long-term follow-up studies that can provide further
information are needed.
The scores for impairment at work and daily activity
impairment were worse in patients who were afraid of
being unable to work, being dependent on someone, being
disabled, being unable to do daily activities, and having a
stroke compared to others in the group. The intensity of
pain also seemed to be a correlating factor. Moreover, fear
regarding losing a job was related to impairment at work,
whereas fear of being blind was correlated with impairment
in daily activities. In our previous study, significant
relationships were observed between fatigue, depression,
anxiety, and disease activity in BD patients (29). Such
symptoms could prevent patients from participating in
regular daily activities and social relationships, and overall
improvement in well-being is a key point in chronic
disease management (2,38,39). Patient-reported outcome
measures could be different from a physicians’ perspective,
but they could give critical information for the decisionmaking procedure. If predictive factors or potential
triggering conditions could be identified, productivity and
emotional distress could be decreased in BD patients.

Although this was the first study to examine the
links between work-related fears and impairments in
working status and daily life in patients with BD, there
remain some limitations. First, productivity loss at work
and in daily life was evaluated in the very short-term
due to the properties of the questionnaire. Second, the
number of female employees was comparatively low in
our patient population. Third, patients were administered
the questionnaires at a single time-point; therefore,
longitudinal data could not be obtained. Fourth, disease
control and healthy control groups were not included in the
study. However, it provided valuable data on a vulnerable
group of BD patients regarding work-related concerns,
patients who may need extra support to be able to cope
with these fears. Moreover, we do not know whether a
relationship between work productivity and depression/
anxiety is present or not. Future studies could be of help to
understand this condition for clinical practice.
In conclusion, we can suggest that the highest levels of
lost productivity and the most severe effects on daily life
are consequences of eye and musculoskeletal involvement
in BD. Although more effective therapeutic approaches
can be expected to improve the working lives of patients,
further longitudinal studies in different populations remain
necessary to expand the amount of available knowledge
regarding the effects of BD on daily life and productivity.
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